Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2022
Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using <sup>18</sup>F-FDG PET
Martin H Cherk, Robert Khor, Thomas W Barber, et al.
Frontiers in Cardiovascular Medicine
|
January 2, 2023
Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
Hayley T Dillon, Stephen Foulkes, Yuki A Horne-Okano, et al.
Scientific Reports
|
February 6, 2023
Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
Hayley T Dillon, Stephen Foulkes, Yuki A Horne-Okano, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 7, 2015
Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendations
Michael Jefford, Nicole Kinnane, Paula Howell, et al.
Transfusion
|
July 16, 2015
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation
Tina Pham, Sushrut Patil, Shaun Fleming, et al.
BMC Cancer
|
August 17, 2022
Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
Hayley T Dillon, Nicholas J Saner, Tegan Ilsley, et al.
Blood
|
September 21, 2007
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia
Eduardo Olavarria, Shamyla Siddique, Michael J Griffiths, et al.
Blood
|
March 5, 2015
Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML
Sewa Rijal, Shaun Fleming, Nik Cummings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2020
Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)
Daniel D Murray, John Zaunders, Samuel T Milliken, et al.
Circulation
|
November 4, 2024
Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial
Hayley T Dillon, Nicholas J Saner, Tegan Ilsley, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
April 22, 2022
Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using <sup>18</sup>F-FDG PET
Martin H Cherk, Robert Khor, Thomas W Barber, et al.
Frontiers in Cardiovascular Medicine
|
January 2, 2023
Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
Hayley T Dillon, Stephen Foulkes, Yuki A Horne-Okano, et al.
Scientific Reports
|
February 6, 2023
Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
Hayley T Dillon, Stephen Foulkes, Yuki A Horne-Okano, et al.
Asia-Pacific Journal of Clinical Oncology
|
August 7, 2015
Implementing novel models of posttreatment care for cancer survivors: Enablers, challenges and recommendations
Michael Jefford, Nicole Kinnane, Paula Howell, et al.
Transfusion
|
July 16, 2015
Comparison of biosimilar filgrastim with originator filgrastim for peripheral blood stem cell mobilization and engraftment in patients with multiple myeloma undergoing autologous stem cell transplantation
Tina Pham, Sushrut Patil, Shaun Fleming, et al.
BMC Cancer
|
August 17, 2022
Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
Hayley T Dillon, Nicholas J Saner, Tegan Ilsley, et al.
Blood
|
September 21, 2007
Posttransplantation imatinib as a strategy to postpone the requirement for immunotherapy in patients undergoing reduced-intensity allografts for chronic myeloid leukemia
Eduardo Olavarria, Shamyla Siddique, Michael J Griffiths, et al.
Blood
|
March 5, 2015
Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML
Sewa Rijal, Shaun Fleming, Nik Cummings, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
June 11, 2020
Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)
Daniel D Murray, John Zaunders, Samuel T Milliken, et al.
Circulation
|
November 4, 2024
Preventing Allogeneic Stem Cell Transplant-Related Cardiovascular Dysfunction: ALLO-Active Trial
Hayley T Dillon, Nicholas J Saner, Tegan Ilsley, et al.
Page
of 5